Results 51 to 60 of about 71,079 (262)

Mechanisms of development of antipsychotic-induced metabolic disorders: pharmacogenetic aspect

open access: yesБюллетень сибирской медицины, 2018
Antipsychotics are the main drug group in the treatment of disorders of the schizophrenic spectrum. At the same time, this drug group requires long-term use, has a narrow therapeutic breadth and a large spectrum and high severity of undesirable drug ...
R. F. Nasyrova   +4 more
doaj   +1 more source

Visual Responsivity in Autism: Measuring Visual Responses in Autistic and Non‐Autistic Adults Using Psychophysics, fMRI, and EEG

open access: yesAutism Research, EarlyView.
ABSTRACT Autistic individuals frequently report heightened sensitivity to visual stimuli, often described as discomfort in environments with bright or flickering lights. These experiences are hypothesized to reflect underlying differences in sensory gain or neural hyperexcitability; however, findings across studies have yielded mixed results, likely ...
Daniela L. Seczon   +6 more
wiley   +1 more source

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

open access: yes, 2022
Hepatology, EarlyView.
Robert J. Fontana   +6 more
wiley   +1 more source

Characteristics of eye disorders induced by atypical antipsychotics: a real-world study from 2016 to 2022 based on Food and Drug Administration Adverse Event Reporting System

open access: yesFrontiers in Psychiatry
BackgroundCommon atypical antipsychotics include risperidone, paliperidone, olanzapine, lurasidone, quetiapine, clozapine, aripiprazole, ziprasidone, asenapine, brexpiprazole, and cariprazine.
Chao Mu, Li Chen
doaj   +1 more source

The prevalence of metabolic syndrome in patients receiving antipsychotics in Qatar: a cross sectional comparative study

open access: yesBMC Psychiatry, 2018
Background Metabolic abnormalities are common in patients maintained on antipsychotics. These abnormalities increase the risk of cardiovascular diseases and mortality in this population.
Samer Hammoudeh   +14 more
doaj   +1 more source

Intact Visual Correlation Detection in Autistic Adults

open access: yesAutism Research, EarlyView.
ABSTRACT The ability to detect recurring temporal co‐occurrence, or temporal correlation, of sensory events is fundamental for organizing perceptual input into coherent representations. Although past work has revealed differences across several aspects of temporal processing in autism, it is unknown whether autistic and non‐autistic individuals differ ...
Lukas Vogelsang   +6 more
wiley   +1 more source

Efficacy of atypical antipsychotics in schizophrenia patients: effects of 5-HTR SNPs

open access: yesAnnals of General Psychiatry
The 5-hydroxytryptamine receptor (5-HTR) is a key protein responsible for the effects of 5-hydroxytryptamine (5-HT) and an important target for many antipsychotics.
Keying Liu   +8 more
doaj   +1 more source

Characterization of Anticholinergic Medication Use and Its Associations With Everyday Memory Problems and Cognitive Decline in Autistic Adults With Higher Support Needs

open access: yesAutism Research, EarlyView.
ABSTRACT Among older adults in the general population, medications with anticholinergic (AC) effects are associated with declines in cognitive functioning and with dementia and Alzheimer's disease. Autistic people have high rates of co‐occurring medical conditions and polypharmacy across the lifespan; thus, they may be at particularly high risk of ...
Goldie A. McQuaid   +2 more
wiley   +1 more source

Antipsychotics [PDF]

open access: yesJournal of Pain and Symptom Management, 2011
Paul, Howard   +4 more
openaire   +3 more sources

Attitudes of European physicians towards the use of long-acting injectable antipsychotics

open access: yesBMC Psychiatry, 2020
Background Prescription rates for long-acting injectable (LAI) antipsychotic formulations remain relatively low in Europe despite improved adherence over alternative oral antipsychotic treatments.
Maxine X. Patel   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy